376 related articles for article (PubMed ID: 34518441)
1. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
2. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
4.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
5. KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
Liang H; Zhou G; Lv L; Lu J; Peng J
Breast Cancer; 2021 Mar; 28(2):379-386. PubMed ID: 33067762
[TBL] [Abstract][Full Text] [Related]
6. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
7. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
8. REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer.
Liu GH; Tan XY; Xu ZY; Li JX; Zhong GH; Zhai JW; Li MY
Sci Rep; 2024 Jun; 14(1):13834. PubMed ID: 38879709
[TBL] [Abstract][Full Text] [Related]
9. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.
Lin T; Qiu Y; Peng W; Peng L
Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
[TBL] [Abstract][Full Text] [Related]
10. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
[TBL] [Abstract][Full Text] [Related]
12. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
13. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
14. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
16. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
[TBL] [Abstract][Full Text] [Related]
17. Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
Mu G; Ji H; He H; Wang H
Breast Cancer; 2021 Mar; 28(2):513-526. PubMed ID: 33245478
[TBL] [Abstract][Full Text] [Related]
18. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
[No Abstract] [Full Text] [Related]
19. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
Chen B; Zhang S; Li Q; Wu S; He H; Huang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers.
Liu X; Xu Q; Li Z; Xiong B
Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]